Obesity… From Diabetes to Inflammation: The Expanding Therapeutic Landscape of GLP-1 receptor agonists and Multi-Hormone Receptor Modulators 10 Dec 202521 Nov 2026 Glucagon-like peptide-1 (GLP-1) receptor agonists have attracted significant attention as a relatively new class of drugs. Initially developed for diabetes management, their therapeutic scope quickly expanded beyond glycemic control. They…